Voices of People with Albinism
Research Update: Funding Source Correction for Dengue Vaccine Study
Health & Sun Protection··1 min read

Research Update: Funding Source Correction for Dengue Vaccine Study

Journal of Investigative Dermatology publishes important correction to acknowledge NIGMS funding in dengue vaccine skin reaction research.

A research team has recently published an important correction to their study on skin reactions following dengue vaccination. The correction, published in the Journal of Investigative Dermatology, addresses an oversight in acknowledging research funding sources.

According to the corrigendum (formal correction), the authors inadvertently omitted mentioning that their research was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health. The specific grant acknowledged in the correction was award number P20GM125498.

The original study examined localized inflammation in dengue vaccine-induced skin rashes and their relationship to the presence of dengue virus genome. This type of meticulous research is vital to understanding potential side effects of vaccines and improving medical care for all patients, including those with albinism who may have unique skin sensitivities.

Proper attribution of research funding is an essential aspect of scientific transparency, allowing readers to understand the supporting institutions behind medical advances. This correction ensures that all contributing organizations receive appropriate recognition for their support of this dermatological research.

Keywords

Core topics and entities mentioned in this summary.

research-updatedermatologymedical-fundingscientific-transparencyskin-research
Research Update: Funding Source Correction for Dengue Vaccine Study | Voices of People with Albinism | Voices of People with Albinism